Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Oct;1(4):254-62.
doi: 10.1016/j.coviro.2011.08.002.

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic

Andrew J Broadbent  1 , Kanta Subbarao
Affiliations
Review

Influenza virus vaccines: lessons from the 2009 H1N1 pandemic

Andrew J Broadbent et al. Curr Opin Virol. 2011 Oct.

Abstract

Reflecting on the 2009 H1N1 pandemic, we summarize lessons regarding influenza vaccines that can be applied in the future. The two major challenges to vaccination during the 2009 H1N1 pandemic were timing and availability of vaccine. Vaccines were, however, well-tolerated and immunogenic, with inactivated vaccines containing 15μg of HA generally inducing antibody titers ≥1:40 in adults within 2 weeks of the administration of a single dose. Moreover, the use of oil-in-water adjuvants in Europe permitted dose- reduction, with vaccines containing as little as 3.75 or 7.5μg HA being immunogenic. Case-control studies demonstrated that monovalent 2009 H1N1 vaccines were effective in preventing infection with the 2009 H1N1 virus, but preliminary data suggests that it is important for individuals to be re-immunized annually.

Keywords: 2009 H1N1; influenza; pandemic; vaccines.

PubMed Disclaimer

Figures

Figure 1
Figure 1
The number of cases in the 2009 H1N1 pandemic in Canada with respect to availability of vaccine (adapted from Skowronski et al., 2011) The number of cases in the 2009 H1N1 pandemic peaked at week 43, coinciding with the first vaccine availability
See this image and copyright information in PMC

References

    1. Palese P, Shaw M. Orthomyxoviridae: The Viruses and Their Replication. In: Knipe D, Griffin D, Lamb R, Straus S, Howley P, Martin M, Roizman B, editors. Fields Viroloy. Vol. 2 Wolters Kluwer: Lippincott Williams & Wilkins; 2007. pp. 1647–1689.
    1. Wright P, Neumann G, Kawaoka Y. Orthomyxoviruses. In: Knipe D, Griffin D, Lamb R, Straus S, Howley P, Martin M, Roizman B, editors. Fields Viroloy. Vol. 2 Wolters Kluwer: Lippincott Williams & Wilkins; 2007. pp. 1691–1740.
    1. Girard MP, Tam JS, Assossou OM, Kieny MP. The 2009 A (H1N1) influenza virus pandemic: A review. Vaccine. 28:4895–4902. A comprehensive review article from the World Health Organization giving an overview of the 2009 H1N1 influenza pandemic. Etiology, epidemiology, clinical observations, and control efforts are discussed. - PubMed
    1. Cox NJ, Subbarao K. Influenza. Lancet. 1999;354:1277–1282. - PubMed
    1. Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. J Infect Dis. 2006;194 (Suppl 2):S111–118. - PubMed

MeSH terms

Substances